Metabolism and global protein glycosylation are differentially expressed in healthy and osteoarthritic equine carpal synovial fluid.
Authors: Noordwijk Kira J, Qin Rui, Diaz-Rubio Maria E, Zhang Sheng, Su Jin, Mahal Lara K, Reesink Heidi L
Journal: Equine veterinary journal
Summary
# Editorial Summary Carpal osteoarthritis represents a significant welfare and economic concern in equine athletes, yet early detection and understanding of disease mechanisms remain challenging. Noordwijk and colleagues used advanced analytical techniques—liquid chromatography mass spectrometry and lectin microarray analysis—to profile metabolic and glycosylation changes in synovial fluid from healthy horses and those with naturally occurring carpal OA, comparing 6 healthy with 6 osteoarthritic joints in the metabolomics phase and 20 paired samples in the glycomics phase. The research identified 84 differentially expressed metabolites involved in critical inflammatory and degenerative pathways (including histidine, tryptophan and lysine metabolism), alongside distinct glycosylation signatures in OA fluid characterised by increased Core 1/Core 3 O-glycosylation, heightened α-2,3 sialylation, reduced α-1,2 fucosylation, and elevated lubricin levels. For equine practitioners, these findings establish a biochemical fingerprint of OA that could form the basis of non-invasive synovial fluid biomarker panels for earlier diagnosis and disease monitoring, whilst the identified metabolic pathways offer potential therapeutic intervention points beyond current management strategies. Further validation studies with larger cohorts and clinically defined OA populations are needed before lectin microarrays or targeted metabolomic screening become routine diagnostic tools.
Read the full abstract on PubMed
Practical Takeaways
- •Synovial fluid biomarkers identified in this study (specific metabolites and glycosylation patterns) could potentially improve early diagnosis of carpal OA before clinical signs become apparent
- •Lubricin elevation in OA joints suggests potential therapeutic targets; monitoring changes in synovial fluid composition may help track disease progression and response to treatment
- •Lectin microarray technology shows promise as a practical screening tool for equine OA diagnosis and could be developed into a clinical test for routine lameness evaluation
Key Findings
- •84 metabolites were differentially expressed between healthy and OA synovial fluid, with key dysregulation in histidine, tryptophan, arginine, and lysine metabolism pathways
- •Distinct glycosylation patterns in OA synovial fluid included increased Core 1/Core 3 O-glycosylation, increased α-2,3 sialylation, and decreased α-1,2 fucosylation compared to healthy joints
- •Synovial fluid lubricin levels were significantly increased in OA joints compared to controls
- •Lectin microarray analysis demonstrated clear separation between healthy and OA synovial fluid samples, with O-glycans predominating over N-glycans in all samples